FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
Canaccord Genuity analyst Bill Maughan reiterated a Buy rating and $21.00 price target on Delcath Systems (NASDAQ: DCTH).
The analyst commented, "Delcath reported 4Q23 results this morning and gave an update on the early launch of Hepzato, which came available in January for the treatment of metastatic uveal melanoma... More

